Issue 1/2024
Content (18 Articles)
National guidelines for gastric cancer: redundant or needed?
Florian Lordick, Bernhard Wörmann
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer
Florian Lordick, Salah-Eddin Al-Batran, Dirk Arnold, Markus Borner, Christiane J. Bruns, Wolfgang Eisterer, Gerhard Faber, Ines Gockel, Dieter Köberle, Sylvie Lorenzen, Markus Möhler, Ron Pritzkuleit, Michael Stahl, Peter Thuss-Patience, Ewald Wöll, Thomas Zander, Georg Maschmeyer
Ethnic-specific associations between body mass index and gastric cancer: a Mendelian randomization study in European and Korean populations
Sangjun Lee, Sue K. Park
Helicobacter pylori testing prior to or at gastric cancer diagnosis and survival in a diverse US patient population
Katherine S. Garman, HannahSofia Brown, Priya Alagesan, Shannon J. McCall, Steven Patierno, Qichen Wang, Frances Wang, Terry Hyslop, Meira Epplein
Randomized controlled trial comparing the costs of gastric cancer screening systems between serological risk-based upper gastrointestinal endoscopy and the existing barium photofluorography: gastric cancer screening labeled by serum examination in place of aged gastric cancer organized screening systems (GALAPAGOS study)
Takuji Gotoda, Hideki Ishikawa, Chika Kusano, Sho Suzuki, Hirohide Ohnishi, Kentaro Sugano, Yutaka Matsuyama
N6-methyladenosine modification of OIP5-AS1 promotes glycolysis, tumorigenesis, and metastasis of gastric cancer by inhibiting Trim21-mediated hnRNPA1 ubiquitination and degradation
Rongjun Xie, Longfei Liu, Xianzhou Lu, Chengjian He, Hongyi Yao, Guoxin Li
Stroma AReactive Invasion Front Areas (SARIFA) proves prognostic relevance in gastric carcinoma and is based on a tumor–adipocyte interaction indicating an altered immune response
Bianca Grosser, Christian M. Heyer, Johannes Austgen, Eva Sipos, Nic G. Reitsam, Andreas Hauser, Alison VanSchoiack, David Kroeppler, Dmytro Vlasenko, Andreas Probst, Alexander Novotny, Wilko Weichert, Gisela Keller, Matthias Schlesner, Bruno Märkl
Gastric tubular adenocarcinoma with diffuse neutrophils infiltrating: characteristics and probable treatment strategy
Bingzhi Wang, Yongjian Zhu, Shaoming Wang, Zhuo Li, Long Wang, Wei Rao, Na Cheng, Rongshan Chen, Jianming Ying, Liyan Xue
Effect of preoperative chemotherapy on the histopathological classification of gastric cancer
I. A. Caspers, H. D. Biesma, K. Wiklund, F. Pontén, P. Lind, M. Nordsmark, K. Sikorska, E. Meershoek-KleinKranenbarg, H. H. Hartgrink, C. J. H. van de Velde, J. W. van Sandick, M. Verheij, A. Cats, N. C. T. van Grieken
DNA mismatch repair deficiency and outcomes of patients with locally advanced gastric cancer treated with preoperative docetaxel, oxaliplatin, and S-1 plus surgery and postoperative S-1 or surgery plus postoperative S-1: a sub-analysis of the phase 3 PRODIGY trial
Jaewon Hyung, Hyungwoo Cho, Hyung-Don Kim, Young Soo Park, Meesun Moon, Min-Hee Ryu, Yoon-Koo Kang
Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study
Choong-kun Lee, Jii Bum Lee, Se Jung Park, Jingmin Che, Woo Sun Kwon, Hyo Song Kim, Minkyu Jung, Seulkee Lee, Sook Ryun Park, Dong-Hoe Koo, Hyun Woo Lee, Woo Kyun Bae, Hei-Cheul Jeung, In Gyu Hwang, Hyunki Kim, Chung Mo Nam, Hyun Cheol Chung, Sun Young Rha
Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry
Pablo Pérez-Wert, Ana Custodio, Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, Arturo Lecumberri, Diego Cacho Lavin, Itsaso Losantos García, Ana Fernández Montes, Juana María Cano, María Luisa Limón, Raquel Hernández San Gil, Marc Diez, Rosario Vidal Tocino, Ismael Macías Declara, Laura Visa, Paola Pimentel Cáceres, Mireia Gil Raga, Elia Martínez Moreno, Tamara Sauri, Marta Martín Richard, Mónica Granja, Paula Cerdà, Lucía Gómez González, Antonio Mérida-García, Maribel Ruiz Martín, Javier Gallego
Clinical outcomes of Epstein–Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet chemotherapy
Eo Jin Kim, Heejung Chae, Young-Soo Park, Min-Hee Ryu, Hyung-Don Kim, Junyoung Shin, Yang Soon Park, Mee Sun Moon, Yoon-Koo Kang
5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer
Takaki Yoshikawa, Masanori Terashima, Junki Mizusawa, Souya Nunobe, Yasunori Nishida, Takanobu Yamada, Masahide Kaji, Takashi Nomura, Shinji Hato, Yasuhiro Choda, Hiroshi Yabusaki, Kazuhiro Yoshida, Kazunari Misawa, Toru Masuzawa, Masahiro Tsuda, Yasuyuki Kawachi, Hiroshi Katayama, Haruhiko Fukuda, Yukinori Kurokawa, Narikazu Boku, Takeshi Sano, Mitsuru Sasako
A nonrandomized controlled trial: long-term outcomes of LATG/LAPG for cStage I gastric cancer: Japan Clinical Oncology Group Study JCOG1401
Chikara Kunisaki, Hitoshi Katai, Shinichi Sakuramoto, Junki Mizusawa, Hiroshi Katayama, Shinichi Kadoya, Takanobu Yamada, Takahiro Kinoshita, Takaki Yoshikawa, Masanori Terashima
Identifying the best candidates for reduced port gastrectomy
Jae Hun Chung, Jawon Hwang, Sung Hyun Park, Ki-Yoon Kim, Minah Cho, Yoo Min Kim, Hye Jung Shin, Si-Hak Lee, Sun-Hwi Hwang, Woo Jin Hyung, Hyoung-Il Kim
Automatic surgical phase recognition-based skill assessment in laparoscopic distal gastrectomy using multicenter videos
Masaru Komatsu, Daichi Kitaguchi, Masahiro Yura, Nobuyoshi Takeshita, Mitsumasa Yoshida, Masayuki Yamaguchi, Hibiki Kondo, Takahiro Kinoshita, Masaaki Ito